cytarabine and Multiple Sclerosis

cytarabine has been researched along with Multiple Sclerosis in 13 studies

Research

Studies (13)

Timeframe	Studies, this research(%)	All Research%
pre-1990	4 (30.77)	18.7374
1990's	0 (0.00)	18.2507
2000's	5 (38.46)	29.6817
2010's	2 (15.38)	24.3611
2020's	2 (15.38)	2.80

Authors

Authors	Studies
Ghraichy, M; Jelcic, I; Martin, R; Müller, AM; Ruder, J; Schanz, U; Trück, J; von Niederhäusern, V	1
Chen, BY; Clark, PM; Ghezzi, C; Quon, A; Radu, CG; Villegas, B; Witte, ON	1
Martin, R; Schippling, S	1
Barreira, AA; Barros, GM; Barros, JC; Brum, DG; Burt, RK; Hamerschlak, N; Kutner, JM; Madeira, MI; Mastropietro, AP; Moraes, DA; Neto, JZ; Oliveira, EA; Oliveira, MC; Paes, AT; Pieroni, F; Porto, PP; Ribeiro, AA; Rodrigues, M; Santana, CL; Santos, AC; Simões, BP; Stracieri, AB; Tylberi, CP; Voltarelli, JC	1
Havrdová, E; Kemlink, D; Kobylka, P; Kovárová, I; Kozák, T; Krasulová, E; Lhotáková, P; Pohlreich, D; Trneny, M; Vacková, B	1
Bosi, A; Bruzzi, P; Di Bartolomeo, P; Donelli, A; Filippi, M; Gualandi, F; Guerrasio, A; La Nasa, G; Mancardi, GL; Marmont, AM; Murialdo, A; Pagliai, F; Papineschi, F; Saccardi, R; Scappini, B; Solari, A	1
Dong, HQ; Ji, BX; Lu, CY; Lu, DP; Su, L; Wan, SG; Xu, J; Yu, YY	1
Baumhefner, RW; Ma, BI; Mendez, M; Potvin, AR; Potvin, JH; Syndulko, K; Tourtellotte, WW	1
Gregora, E; Havrdová, E; Kobylka, P; Kozák, T; Maaloufová, J; Marecková, H; Pit'ha, J; Pytlík, R; Vodvárková, S	1
Gregora, E; Havrdová, E; Kobylka, P; Kozák, T; Maaloufová, J; Pit'ha, J; Pytlík, R; Vodvárková, S	1
Buckman, R; Gore, M; Stern, G	1
Durkos-Smith, D; Ellison, GW; Fahey, JL; Moody, DJ; Myers, LW	1
Cendrowski, W; Riekkinen, PJ; Rinne, UK	1

Reviews

2 review(s) available for cytarabine and Multiple Sclerosis

Article	Year
[Stem cell therapy in multiple sclerosis: a clinical update]. Zeitschrift fur Rheumatologie, 2009, Volume: 68, Issue:3 Topics: Animals; Antilymphocyte Serum; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Purging; Bone Marrow Transplantation; Carmustine; Central Nervous System; Clinical Trials, Phase II as Topic; Controlled Clinical Trials as Topic; Cytarabine; Hematopoietic Stem Cell Transplantation; Humans; Immunosuppressive Agents; Magnetic Resonance Imaging; Melphalan; Mitoxantrone; Multicenter Studies as Topic; Multiple Sclerosis; Podophyllotoxin; Risk Assessment; Survival Rate; Treatment Outcome	2009
Immunosuppressive therapy in neurological diseases. Annals of clinical research, 1974, Volume: 6, Issue:6 Topics: Adrenocorticotropic Hormone; Azathioprine; Central Nervous System Diseases; Cyclophosphamide; Cytarabine; Encephalitis; Female; Humans; Hydrocortisone; Immunity, Cellular; Immunosuppressive Agents; Lupus Erythematosus, Systemic; Lymphocyte Activation; Methotrexate; Multiple Sclerosis; Myasthenia Gravis; Myositis; Neuritis; Polyradiculopathy; Prednisone; Virus Diseases	1974

Article

Year

[Stem cell therapy in multiple sclerosis: a clinical update].

Zeitschrift fur Rheumatologie, 2009, Volume: 68, Issue:3

Topics: Animals; Antilymphocyte Serum; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Purging; Bone Marrow Transplantation; Carmustine; Central Nervous System; Clinical Trials, Phase II as Topic; Controlled Clinical Trials as Topic; Cytarabine; Hematopoietic Stem Cell Transplantation; Humans; Immunosuppressive Agents; Magnetic Resonance Imaging; Melphalan; Mitoxantrone; Multicenter Studies as Topic; Multiple Sclerosis; Podophyllotoxin; Risk Assessment; Survival Rate; Treatment Outcome

2009

Immunosuppressive therapy in neurological diseases.

Annals of clinical research, 1974, Volume: 6, Issue:6

Topics: Adrenocorticotropic Hormone; Azathioprine; Central Nervous System Diseases; Cyclophosphamide; Cytarabine; Encephalitis; Female; Humans; Hydrocortisone; Immunity, Cellular; Immunosuppressive Agents; Lupus Erythematosus, Systemic; Lymphocyte Activation; Methotrexate; Multiple Sclerosis; Myasthenia Gravis; Myositis; Neuritis; Polyradiculopathy; Prednisone; Virus Diseases

1974

Trials

4 trial(s) available for cytarabine and Multiple Sclerosis

Article	Year
Brazilian experience with two conditioning regimens in patients with multiple sclerosis: BEAM/horse ATG and CY/rabbit ATG. Bone marrow transplantation, 2010, Volume: 45, Issue:2 Topics: Adult; Animals; Antilymphocyte Serum; Antineoplastic Combined Chemotherapy Protocols; Carmustine; Cytarabine; Etoposide; Female; Graft Rejection; Hematopoietic Stem Cell Mobilization; Hematopoietic Stem Cell Transplantation; Horses; Humans; Male; Melphalan; Middle Aged; Multiple Sclerosis; Quality of Life; Rabbits; Transplantation Conditioning	2010
High-dose immunosuppressive therapy with PBPC support in the treatment of poor risk multiple sclerosis. Bone marrow transplantation, 2000, Volume: 25, Issue:5 Topics: Adolescent; Adult; Antigens, CD; Antineoplastic Combined Chemotherapy Protocols; Carmustine; CD4-CD8 Ratio; Cytarabine; Etoposide; Female; Fever; Follow-Up Studies; Graft Survival; Hematopoietic Stem Cell Mobilization; Hematopoietic Stem Cell Transplantation; Humans; Immunosuppressive Agents; Infections; Leukapheresis; Lymphocyte Subsets; Magnetic Resonance Imaging; Male; Melphalan; Middle Aged; Multiple Sclerosis; Neutropenia; Prognosis; Severity of Illness Index	2000
Immunoablative therapy with autologous stem cell transplantation in the treatment of poor risk multiple sclerosis. Transplantation proceedings, 2001, Volume: 33, Issue:3 Topics: Adrenal Cortex Hormones; Adult; Carmustine; Combined Modality Therapy; Cyclophosphamide; Cytarabine; Drug Therapy, Combination; Etoposide; Granulocyte Colony-Stimulating Factor; Hematopoietic Stem Cell Mobilization; Hematopoietic Stem Cell Transplantation; Humans; Immunosuppressive Agents; Lymphocyte Depletion; Magnetic Resonance Imaging; Melphalan; Middle Aged; Multiple Sclerosis; Patient Selection; T-Lymphocytes	2001
Intrathecal cytarabine in multiple sclerosis. Lancet (London, England), 1979, Jul-28, Volume: 2, Issue:8135 Topics: Clinical Trials as Topic; Cytarabine; Humans; Injections, Spinal; Multiple Sclerosis	1979

Other Studies

7 other study(ies) available for cytarabine and Multiple Sclerosis

Article	Year
B-Cell Reconstitution After Autologous Hematopoietic Stem Cell Transplantation in Multiple Sclerosis. Neurology(R) neuroimmunology & neuroinflammation, 2022, Volume: 9, Issue:6 Topics: Antilymphocyte Serum; Carmustine; Cytarabine; Etoposide; Hematopoietic Stem Cell Transplantation; Humans; Immunoglobulin G; Immunoglobulin Heavy Chains; Melphalan; Multiple Sclerosis	2022
Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 2020, Volume: 61, Issue:5 Topics: Animals; Blood-Brain Barrier; Brain; Cytarabine; Encephalomyelitis, Autoimmune, Experimental; Female; Immunologic Factors; Leukocytes; Mice; Mice, Inbred C57BL; Multiple Sclerosis; Positron-Emission Tomography	2020
High-dose immunoablation with autologous haematopoietic stem cell transplantation in aggressive multiple sclerosis: a single centre 10-year experience. Multiple sclerosis (Houndmills, Basingstoke, England), 2010, Volume: 16, Issue:6 Topics: Adult; Age Factors; Antineoplastic Combined Chemotherapy Protocols; Carmustine; Combined Modality Therapy; Cyclophosphamide; Cytarabine; Disease-Free Survival; Etoposide; Female; Granulocyte Colony-Stimulating Factor; Hematopoietic Stem Cell Transplantation; Humans; Immunosuppression Therapy; Kaplan-Meier Estimate; Male; Melphalan; Multiple Sclerosis; Treatment Outcome	2010
Autologous HSCT for severe progressive multiple sclerosis in a multicenter trial: impact on disease activity and quality of life. Blood, 2005, Mar-15, Volume: 105, Issue:6 Topics: Adult; Antilymphocyte Serum; Antineoplastic Combined Chemotherapy Protocols; Carmustine; Cytarabine; Female; Follow-Up Studies; Hematopoietic Stem Cell Mobilization; Humans; Male; Melphalan; Middle Aged; Multiple Sclerosis; Peripheral Blood Stem Cell Transplantation; Podophyllotoxin; Quality of Life; Radiography; Retrospective Studies; Transplantation Conditioning; Transplantation, Autologous; Treatment Outcome	2005
Autologous peripheral blood stem cell transplantation for severe multiple sclerosis. International journal of hematology, 2006, Volume: 84, Issue:3 Topics: Adult; Antigens, CD34; Antineoplastic Combined Chemotherapy Protocols; Carmustine; Cytarabine; Diarrhea; Disease-Free Survival; Female; Hematopoietic Stem Cell Mobilization; Humans; Liver Diseases; Lymphocyte Depletion; Male; Melphalan; Middle Aged; Mucositis; Multiple Sclerosis; Peripheral Blood Stem Cell Transplantation; Podophyllotoxin; Retrospective Studies; Transplantation Conditioning; Transplantation, Autologous	2006
Failure of intravenous and intrathecal cytarabine to modify central nervous system IgG synthesis in multiple sclerosis. Annals of neurology, 1980, Volume: 8, Issue:4 Topics: Adult; Central Nervous System; Cytarabine; Female; Hemianopsia; Humans; Immunoglobulin G; Injections, Intravenous; Injections, Spinal; Male; Meningism; Middle Aged; Multiple Sclerosis	1980
Cytosine arabinoside induced changes in natural killer and antibody dependent cellular cytotoxicity functions in multiple sclerosis patients. Journal of immunopharmacology, 1986, Volume: 8, Issue:2 Topics: Antibody-Dependent Cell Cytotoxicity; Cytarabine; Humans; In Vitro Techniques; Killer Cells, Natural; Multiple Sclerosis; Receptors, Fc; Receptors, IgG	1986